HalioDx Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 240

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

HalioDx General Information

Description

Developer of a line of immunologic scoring tests intended to investigate the immune response within the tumor environment. The company's tests are developed using a proprietary set of Immune biomarkers, advanced image analysis technologies to precisely measure the immune reaction in and around the tumor, enabling clinicians to determine the degree of severity of the patient's disease and to predict response to treatment.

Contact Information

Website
www.haliodx.com
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Acquirer
Corporate Office
  • 737 North 5th Street
  • Suite 600
  • Richmond, VA
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HalioDx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore HalioDx‘s full profile, request access.

Request a free trial

HalioDx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HalioDx Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore HalioDx‘s full profile, request access.

Request a free trial

HalioDx FAQs

  • When was HalioDx founded?

    HalioDx was founded in 2014.

  • Who is the founder of HalioDx?

    Stéphane Debono, Jérôme Galon Ph.D, Corinne Danan, Fabienne Hermitte Ph.D, and Helene Peyro-Saint-Paul MD are the founders of HalioDx.

  • Where is HalioDx headquartered?

    HalioDx is headquartered in Richmond, VA.

  • What is the size of HalioDx?

    HalioDx has 240 total employees.

  • What industry is HalioDx in?

    HalioDx’s primary industry is Diagnostic Equipment.

  • Is HalioDx a private or public company?

    HalioDx is a Private company.

  • What is the current valuation of HalioDx?

    The current valuation of HalioDx is 00000.

  • What is HalioDx’s current revenue?

    The current revenue for HalioDx is 00000.

  • How much funding has HalioDx raised over time?

    HalioDx has raised $21M.

  • Who are HalioDx’s investors?

    Amundi Private Equity Funds, BNP Paribas Asset Management, Bpifrance, Capricorn Partners, and Grand Luminy are 5 of 9 investors who have invested in HalioDx.

  • When was HalioDx acquired?

    HalioDx was acquired on 02-Aug-2021.

  • Who acquired HalioDx?

    HalioDx was acquired by Veracyte.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »